| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
40,010,000 |
| Market
Cap: |
789.00(M) |
| Last
Volume: |
1,008,943 |
Avg
Vol: |
1,006,214 |
| 52
Week Range: |
$12.64 - $30.11 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Cassava Sciences is a clinical-stage biotechnology company. Co. has combined technology with insights in neurobiology to develop solutions for Alzheimer's disease and other neurodegenerative diseases. Co. has two biopharmaceutical assets under development: its primary therapeutic product candidate, called simufilam, is a treatment for Alzheimer's disease; and its primary investigational diagnostic product candidate, called SavaDx, is a way to detect the existence of Alzheimer's disease from a small sample of blood.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
48,477 |
278,477 |
| Total Buy Value |
$0 |
$0 |
$831,428 |
$6,164,449 |
| Total People Bought |
0 |
0 |
2 |
4 |
| Total Buy Transactions |
0 |
0 |
3 |
9 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Barbier Remi |
President and CEO |
• • • |
2008-11-04 |
4 |
AS |
$8.64 |
$216,000 |
D/D |
(25,000) |
6,844,075 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-11-03 |
4 |
AS |
$8.97 |
$224,250 |
D/D |
(25,000) |
6,869,075 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-11-03 |
4 |
A |
$6.30 |
$5,935 |
I/I |
942 |
43,971 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-11-03 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,500 |
43,029 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-11-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,500 |
6,894,075 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-10-02 |
4 |
AS |
$9.84 |
$246,000 |
D/D |
(25,000) |
6,896,575 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-10-01 |
4 |
AS |
$9.68 |
$242,000 |
D/D |
(25,000) |
6,921,575 |
|
- |
|
| Friedmann Nadav |
Chief Operating & Med.Officer |
• • – |
2008-09-12 |
4 |
A |
$8.56 |
$687,471 |
D/D |
80,312 |
313,884 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-09-12 |
4 |
A |
$8.56 |
$824,970 |
D/D |
96,375 |
6,946,575 |
|
- |
|
| Schoenhard Grant |
Chief Scientific Officer |
• – – |
2008-09-12 |
4 |
A |
$8.56 |
$412,481 |
D/D |
48,187 |
48,187 |
|
- |
|
| Roddy Peter S |
Vice President and CFO |
• – – |
2008-09-12 |
4 |
A |
$8.56 |
$219,992 |
D/D |
25,700 |
51,409 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-09-03 |
4 |
AS |
$9.38 |
$234,500 |
D/D |
(25,000) |
6,850,200 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-09-02 |
4 |
AS |
$9.43 |
$235,750 |
D/D |
(25,000) |
6,875,200 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-08-04 |
4 |
AS |
$8.35 |
$208,750 |
D/D |
(25,000) |
6,775,200 |
|
- |
|
| Friedmann Nadav |
Chief Operating & Med. Officer |
• • – |
2008-08-01 |
4 |
B |
$0.00 |
$0 |
D/D |
25,000 |
233,572 |
2.73 |
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-08-01 |
4 |
AB |
$0.00 |
$0 |
D/D |
125,000 |
6,900,200 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-08-01 |
4 |
AS |
$8.33 |
$208,250 |
D/D |
(25,000) |
6,800,200 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-07-02 |
4 |
AS |
$7.65 |
$191,250 |
D/D |
(25,000) |
6,825,200 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-07-01 |
4 |
AS |
$7.76 |
$194,000 |
D/D |
(25,000) |
6,850,200 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-06-03 |
4 |
AS |
$8.07 |
$201,750 |
D/D |
(25,000) |
6,875,200 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-06-02 |
4 |
AS |
$8.01 |
$200,250 |
D/D |
(25,000) |
6,900,200 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-05-02 |
4 |
AS |
$7.48 |
$187,000 |
D/D |
(25,000) |
6,925,200 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-05-01 |
4 |
A |
$5.74 |
$38,065 |
I/I |
6,628 |
40,529 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-05-01 |
4 |
AS |
$7.27 |
$181,750 |
D/D |
(25,000) |
6,950,200 |
|
- |
|
| Roddy Peter S |
Vice President and CFO |
• – – |
2008-05-01 |
4 |
B |
$6.30 |
$20,583 |
D/D |
3,268 |
25,709 |
2.74 |
- |
|
504 Records found
|
|
Page 12 of 21 |
|
|
0.17 (0.85%) 
